Chargement en cours...

Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C

The results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. At this point, most patients with chronic HCV remain untreated. Thus, it is anticipated that therapy will be more appealing and pres...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nudo, CG, Wong, P, Hilzenrat, N, Deschênes, M
Format: Artigo
Langue:Inglês
Publié: Pulsus Group Inc 2006
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2659944/
https://ncbi.nlm.nih.gov/pubmed/17001400
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!